pharma stocks

Spinraza helps Biogen beat the street in Q1

April 24, 2019

Biocept narrows loss in Q4

March 28, 2019

Why Amarin stock is rallying today

March 28, 2019

Earnings preview: What’s on the cards for Biocept in Q4

March 27, 2019

Earnings: Affimed cuts down losses in 2018

March 27, 2019

Onconova Therapeutics cuts down losses in 2018

March 26, 2019

What is NASH and which biotech firms are vying for the first-mover status

March 20, 2019

Novavax misses Q4 estimates, shares slip

March 18, 2019

Earnings: Trevena slips on wider-than-expected Q4 loss

March 13, 2019

Portola Pharmaceuticals rises on strong Q4 earnings

March 1, 2019

Amarin shares jump 14% on rumors over Novartis interest

February 22, 2019

CVS Health Q4 earnings preview: What to expect

February 16, 2019

Earnings: Oncology unit drives AstraZeneca topline higher in Q4

February 14, 2019

Gilead’s credibility takes a hit on massive NASH-drug failure, rivals jump

February 12, 2019

Earnings: Array BioPharma delivers strong Q2 results, investors cheer

February 5, 2019

Earnings: Pfizer edges past Q4 estimates, shares dip on weak outlook

January 29, 2019

Bristol-Myers Squibb reports Q4 earnings on Jan 24. What to expect

January 23, 2019

Why Ligand Pharma, Viking Therapeutics tumbled yesterday, but is gaining today

January 17, 2019

In a massive deal, Eli Lilly acquires Loxo Oncology

January 7, 2019

Johnson & Johnson dips on revenue decline in India

January 3, 2019

Johnson & Johnson will spend more time in court in 2019

December 28, 2018